Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.750
+0.030 (1.74%)
Sep 18, 2025, 9:25 AM EDT - Market open
Caribou Biosciences Employees
Caribou Biosciences had 147 employees as of December 31, 2024. The number of employees decreased by 11 or -6.96% compared to the previous year.
Employees
147
Change (1Y)
-11
Growth (1Y)
-6.96%
Revenue / Employee
$62,048
Profits / Employee
-$1,117,435
Market Cap
162.97M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CRBU News
- 23 days ago - Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference - GlobeNewsWire
- 5 weeks ago - Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference - GlobeNewsWire
- 5 months ago - Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs - GlobeNewsWire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect - Accesswire
- 5 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out - Accesswire